Acreage Reports Third Quarter 2022 Financial Results

Rhea-AI Summary

Acreage Holdings reported Q3 2022 consolidated revenue of $61.4 million, a 28% year-over-year increase. Adjusted EBITDA rose to $8.8 million, up 36% from Q3 2021. Gross margin decreased to 35% from 49% in Q3 2021, mainly due to inflation and competitive price pressures. Acreage concluded operations in Oregon and achieved adult-use sales in New Jersey. A strategic arrangement with Canopy Growth was announced to facilitate Canopy's acquisition of Acreage, promising future company growth. The company ended the quarter with $26.6 million in cash.

Positive

• Revenue increased 28% year-over-year to $61.4 million.
• Adjusted EBITDA grew by 36% to $8.8 million.
• Expansion in New Jersey with ongoing adult-use sales.
• Strategic arrangement with Canopy Growth for full acquisition.

Negative

• Gross margin decreased to 35% from 49% due to price declines.
• Net loss attributable to Acreage was $(22.2) million, up from $(12.3) million in Q3 2021.
• Operating expenses rose 24.3% year-over-year to $37.7 million, including a $7.2 million bad debt provision.

Delivered robust revenue of $61.4 million for Q3 2022, a 28% increase year-over-year

Continued strong profitability with Adjusted EBITDA* of $8.8M, a 36% increase vs. Q3 2021

Subsequent to quarter-end, entered a new U.S. strategic arrangement with Canopy and amended credit facility to gain immediate access to additional funding

NEW YORK, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Acreage Holdings, Inc. (“Acreage” or the “Company”) (CSE: ACRG.A.U, ACRG.B.U) (OTCQX: ACRHF, ACRDF), a vertically integrated, multi-state operator of cannabis cultivation and retailing facilities in the U.S., today reported its financial results for the third quarter ended September 30, 2022 (“Q3 2022”).

Third Quarter 2022 Financial Highlights

• Consolidated revenue was $61.4 million for Q3 2022, an increase of 28% year-over-year.
• Gross margin of 35% compared to 50% in the second quarter of 2022 (“Q2 2022”). Excluding non-cash inventory adjustments, gross margin was 45% for Q3 2022.
• Adjusted EBITDA* was $8.8 million in Q3 2022, compared to $6.5 million in the third quarter of 2021 (“Q3 2021”). Adjusted EBITDA* as a percentage of consolidated revenue was 14% for Q3 2022.
  

Third Quarter 2022 Operational Highlights

• Concluded operations in Oregon with the completion of the sale of four retail dispensaries in the state branded as Cannabliss & Co.
• Became one of only a small number of producers in the state of New York with the capability to supply non-remediated whole flower to the market upon the launch of the Company’s whole flower sales under the state’s strict microbial testing regulations.
• Continued strong growth in New Jersey with adult-use sales and made continued progress on upgrades to the infrastructure and operating procedures at the Company's Egg Harbor, New Jersey cultivation facility.
• Launched The Botanist Vape Cartridges and Disposables in Illinois, as well as Superflux Cured Concentrates to build on the reputation of the Company's national brands. Further, the Superflux Margalope Live Resin Vape Cartridge took first place in the Vape Pens category of the High Times Cannabis Cup Illinois.
• Subsequent to the end of the quarter, the Company’s social equity joint venture in Connecticut was approved for both a Disproportionately Impacted Area Cultivation License and an Adult-Use Cannabis Retailer license.
  

U.S. Strategic Arrangement with Canopy and Credit Facility Amendment

On October 25, 2022, Acreage announced that it entered into an arrangement agreement (the “Floating Share Agreement”) with Canopy Growth Corporation (“Canopy” or “CGC”) and Canopy USA, LLC (“Canopy USA”), CGC’s newly-created U.S. domiciled holding company, pursuant to which, subject to approval of the holders of the Class D subordinate voting shares of Acreage (the “Floating Shares”) and the terms and conditions of the Floating Share Agreement, Canopy USA will acquire all of the issued and outstanding Floating Shares by way of court-approved plan of arrangement (the “Floating Share Arrangement”).

Concurrent with the entering into of the Floating Share Agreement, Canopy irrevocably waived its option to acquire the Floating Shares pursuant to the plan of arrangement implemented on September 23, 2020 (the “Existing Arrangement”) pursuant to the arrangement agreement between Canopy and Acreage dated April 18, 2019, as amended (the “Existing Arrangement Agreement”). Additionally, subject to the provisions of the Floating Share Agreement, Canopy has agreed to exercise its option pursuant to the Existing Arrangement Agreement (the “Fixed Option”) to acquire Acreage’s outstanding Class E subordinate voting shares (the “Fixed Shares”), representing approximately 70% of the total shares of Acreage. Upon exercise of the Fixed Option and completion of the Floating Share Arrangement, Canopy USA will own 100% of all outstanding Fixed Shares and Floating Shares. The Company intends to hold a special meeting of its shareholders in January 2023.

Additionally, the Company amended its existing US$150 million credit facility (the “Amended Credit Facility”) with AFC Gamma, Inc. and Viridescent Realty Trust, Inc. Under the terms of the Amended Credit Facility, $25 million is available for immediate draw by Acreage with a further US$25 million available in future periods under a committed accordion option once certain predetermined milestones are achieved.

Details regarding the Floating Share Agreement, including the strategic benefits and rationale, Fixed Option, and Amended Credit Facility can be found in the Company's press release dated October 25, 2022.

Management Commentary

“Despite significant industry headwinds, our results in the third quarter once again demonstrate the highly attractive positioning our operations have established in our core markets over the last year. We believe very strongly that our disciplined strategy will continue to foster long-term growth and enhanced value for our business as the markets continue to evolve and our opportunity to drive further profitability increases,” said Peter Caldini, CEO of Acreage. “Throughout the remainder of the year we will focus our efforts on strengthening our presence in New Jersey through continued cultivation improvements and prepare for the launch of adult-use sales in key Northeastern markets.”

Mr. Caldini continued, “The Acreage of today is dramatically different than it was a few years ago, and as the next transformative step in our history, we were pleased to recently announce a new arrangement with Canopy that provides the opportunity for their newly established U.S. domiciled entity, Canopy USA, to gain full ownership of Acreage. This agreement is a culmination of the significant work and effort our teams have put in over the last several years, and we are confident that now is the time to execute on this strategic opportunity.”

Mr. Caldini concluded, “Our industry is in its exciting early days with constant developments taking place, and this new arrangement provides the unique ability for shareholders to participate right at the onset of the creation of Canopy USA. Acreage is a valuable addition to what Canopy is building, and we believe the time is right to build an even stronger position ahead of federal permissibility as part of a leading North American brand powerhouse.”

Q3 2022 Financial Summary
(in thousands)

	Three Months Ended September 30,								YoY% Change		Three Months Ended June 30, 2022				QoQ% Change
		2022				2021
Consolidated Revenue	$61,419				$48,152				27.6%		$61,351				0.1%
Gross Profit		21,226				23,804			(10.8)%			30,614			(30.7)%
% of revenue		35%				49%						50%
Total operating expenses		37,661				30,298			24.3%			27,304			37.9%
Net loss		(24,998)				(14,057)						(10,603)
Net loss attributable to Acreage		(22,214)				(12,296)						(9,929)
Adjusted EBITDA*		8,847				6,498			36.1%			10,385			(14.8)%

Total revenue for Q3 2022 was $61.4 million, an increase of $13.3 million or 28% compared to Q3 2021. The year-over-year improvement was primarily due to the addition of operations in Ohio as well as the commencement of adult-use sales in New Jersey. This revenue growth was somewhat offset by declines in other select markets as category headwinds and competitive pressures negatively impacted both price and volume. Additionally, total revenue for Q3 2022 was in-line with Q2 2022. Excluding the Company’s Oregon operations, which concluded at the very beginning of the quarter upon the completion of the sale of the four remaining dispensaries, revenue for the three months ended September 30, 2022, increased by 2% on a sequential basis.

Total gross profit for Q3 2022 was $21.2 million, compared to $23.8 million in Q3 2021. Total gross margin was 35% in Q3 2022 compared to 49% in Q3 2021. Cost increases due to inflation and price declines due to competition negatively impacted gross margin during the quarter. Additionally, cost of goods sold for Q3 2022 included $6.3 million of non-cash inventory adjustments as a result of excess inventory in select markets and carrying values of inventory exceeding net realizable value. Excluding these non-cash inventory adjustments, margin for Q3 2022 was 45%.

Total operating expenses for Q3 2022 were $37.7 million, compared to $30.3 million in Q3 2021. Included in operating expenses for Q3 2022 was a bad debt provision of $7.2 million related to certain notes receivable amounts where collection is considered doubtful and included in operating expenses for Q3 2021 was an impairment charge of $2.3 million related to capital assets in Sewell, New Jersey that were damaged by Hurricane Ida. Excluding these unusual non-cash items, total operating expenses increased by $2.5 million, or 9%, for Q3 2022 due to increases in compensation and general and administrative expenses as a result of inflation and the Company’s expanded operations and were somewhat offset by reductions in equity-based compensation expense, and depreciation and amortization expenses.

Adjusted EBITDA* for Q3 2022 was $8.8 million compared to Adjusted EBITDA* of $6.5 million in Q3 2021 and Adjusted EBITDA* of $10.4 million in Q2 2022. While the expanded operations and implementation of the Company’s strategic plan led to year-over-year growth in Adjusted EBITDA*, Adjusted EBITDA* on a sequential basis was negatively impacted by decreased pricing due to competitive pressures and increased costs due to inflation. Consolidated EBITDA* for Q3 2022 was a loss of $(9.1) million, compared to a consolidated EBITDA* loss of $(1.3) million in the previous year's comparable period.

Net loss attributable to Acreage for Q3 2022 was $(22.2) million, compared to $(12.3) million in Q3 2021.

Balance Sheet and Liquidity

Acreage ended the quarter with $26.6 million in cash and cash equivalents. As of September 30, 2022, $100.0 million was drawn under the Credit Facility entered in the fourth quarter of 2021. In conjunction with the recently announced Amended Credit Facility, an additional $25 million is available for immediate draw, with a further $25.0 million available in future periods under a committed accordion option once certain, predetermined milestones are achieved. Acreage intends to use the proceeds of the Amended Credit Facility to fund expansion initiatives and provide additional working capital.

Earnings Call

Management will host a conference call on November 8, 2022, at 10:00 a.m. ET to discuss the results in detail.

Webcast:	Register
Dial-in:	Canada – 1-833-950-0062 (toll-free) or 1-226-828-7575 US – 1-844-200-6205 (toll-free) or 1-646-904-5544 International – +1-929-526-1599
Conference ID:	719120

The webcast will be archived and can be accessed via Acreage’s website at investors.acreageholdings.com.

About Acreage Holdings, Inc.

Acreage is a multi-state operator of cannabis ‎cultivation and retailing facilities in the U.S., including the Company’s national retail store ‎brand, The Botanist. With its principal address in New York City, Acreage’s wide range of national and regionally available cannabis products include the award-winning The Botanist brand, craft brand Superflux, the Tweed brand, the Prime medical brand in Pennsylvania, the Innocent brand in Illinois and others. Acreage also owns Universal Hemp, LLC, a hemp subsidiary dedicated to the distribution, marketing and sale of CBD products throughout the U.S. Since its founding in 2011, Acreage has focused on building and scaling operations to create a seamless, consumer-focused, branded experience. Learn more at www.acreageholdings.com and follow us on Twitter, LinkedIn, Instagram, and Facebook.

Forward Looking Statements

This news release and each of the documents referred to herein contains “forward-looking information” and ‎‎“forward-looking statements” within the meaning of applicable Canadian and United States securities legislation, ‎respectively. All statements, other than statements of historical fact, included herein are forward-looking ‎information. ‎Often, but not always, forward-looking statements and information can be identified by the use of words such as ‎‎“plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, ‎or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, ‎‎‎“would”, “might” or “will” be taken, occur or be achieved. ‎

Forward-looking statements or information involve known and unknown risks, uncertainties, and other ‎factors which may cause the actual results, performance or achievements of Acreage or its ‎subsidiaries to be materially different from any future results, performance or achievements expressed or ‎implied by the forward-looking statements or information contained in this news release. Examples of such statements include statements with respect to the timing and outcome of the Floating Share Arrangement, the anticipated benefits of the Floating Share Arrangement, the timing of the closing of the Fixed Shares pursuant to the Existing Arrangement, the anticipated timing of the special meeting, the anticipated strategic benefits of the acquisition of the Fixed Shares and the Floating Shares by Canopy USA, the anticipated increased liquidity of Canopy Shares, the anticipated long-term value of holding Canopy Shares, the ability of Acreage to leverage Canopy’s strategic platform and participate in the revenue and cost synergies expected to be achieved by Canopy USA, Canopy strengthening its position as a brand powerhouse, the expectation that the United States is going to be a core market for Canopy, the formation of a pre-eminent global cannabis company, the satisfaction or waiver of all conditions under the Floating Share Agreement and the Existing Arrangement, the timing and ability of Acreage to achieve the milestones under the Amended Credit Facility, and the proposed use of proceeds under the Amended Credit Facility.

Risks, uncertainties and other factors involved with forward-looking ‎information could cause actual events, results, performance, prospects and opportunities to differ ‎materially from those expressed or implied by such forward-looking information, including, but not limited to: the occurrence of changes in U.S. federal laws regarding the cultivation, distribution or possession of marijuana; assumptions as to the time required to prepare and mail materials to Acreage shareholders in respect of the special meeting; the ability of the parties to receive, in a timely manner and on satisfactory terms, the necessary regulatory, court and shareholder approvals; the ability of the parties to satisfy, in a timely manner, the other conditions to the completion of the Floating Share Arrangement Agreement and the Existing Arrangement Agreement; in the event that the Floating Share Arrangement is not adopted, the likelihood of completion of the acquisition of the Floating Shares pursuant to an alternative transaction; in the event that the Floating Share Arrangement is not adopted, the likelihood of Canopy Growth completing the acquisition of the Fixed Shares under the Existing Arrangements; other expectations and assumptions concerning the transactions contemplated between Canopy Growth and/or Canopy USA, as applicable, and Acreage; the available funds of Acreage and the anticipated use of such funds; the availability of financing opportunities for Acreage and the risks associated with the completion thereof; regulatory and licensing risks; changes in general economic, business and political conditions, including changes in the financial and stock markets; legal and regulatory risks inherent in the cannabis industry, including the global regulatory landscape and enforcement related to cannabis, political risks and risks relating to regulatory change; risks relating to anti-money laundering laws; compliance with extensive government regulation and the interpretation of various laws regulations and policies; public opinion and perception of the cannabis industry; and such other risks disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, dated March 11, 2022 and the Company’s other public filings, in each case filed with the U.S. Securities and Exchange Commission on the EDGAR website at www.sec.gov and with Canadian securities regulators and available under Acreage’s profile on SEDAR at www.sedar.com. Although Acreage has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended.

Although Acreage believes that the ‎assumptions and factors used in preparing the forward-looking information or forward-looking ‎statements in this news release are reasonable, undue reliance should not be placed on such information ‎and no assurance can be given that such events will occur in the disclosed time frames or at all. The ‎forward-looking information and forward-looking statements included in this news release are made as of ‎the date of this news release and Acreage does not undertake any obligation to publicly update such ‎forward-looking information or forward-looking statements to reflect new information, subsequent events ‎or otherwise unless required by applicable securities laws. There can be no assurance that the Floating Share Arrangement will occur, or that such events will occur on the terms and conditions contemplated in this news release. The Floating Share Agreement could be modified, restructured or terminated. Actual results could differ materially from those currently anticipated due to a number of factors and risks. The Floating Share Arrangement cannot close until the required shareholder, court and regulatory approval is obtained. Investors are cautioned that, except as disclosed in the management information circular of Acreage to be prepared in connection with the Floating Share Arrangement, any information released or received with respect to the Floating Share Arrangement may not be accurate or complete and should not be relied upon.

Neither the Canadian Securities Exchange nor its Regulation Service Provider has reviewed and does not accept ‎responsibility for the adequacy or accuracy of the content of this news release.‎

For more information, contact:

Steve Goertz
Chief Financial Officer
investors@acreageholdings.com

Courtney Van Alstyne
MATTIO Communications
acreage@mattio.com

US GAAP FINANCIAL HIGHLIGHTS (UNAUDITED)

US GAAP Statements of Financial Position
US$ (thousands)	September 30, 2022			December 31, 2021
	(unaudited)			(audited)
ASSETS
Cash and cash equivalents	$	26,476		$	43,180
Restricted cash		95			1,098
Accounts receivable, net		9,466			8,202
Inventory		50,892			41,804
Notes receivable, current		2,500			7,104
Assets held-for-sale		—			8,952
Other current assets		3,843			2,639
Total current assets		93,272			112,979
Long-term investments		34,328			35,226
Notes receivable, non-current		27,343			27,563
Capital assets, net		135,362			126,797
Operating lease right-of-use assets		22,730			24,598
Intangible assets, net		135,807			119,695
Goodwill		30,492			43,310
Other non-current assets		3,563			1,383
Total non-current assets		389,625			378,572
TOTAL ASSETS	$	482,897		$	491,551
LIABILITIES AND MEMBERS’ EQUITY
Accounts payable and accrued liabilities	$	26,082		$	23,861
Taxes payable		29,240			24,572
Interest payable		1,167			1,432
Operating lease liability, current		2,298			2,145
Debt, current		7,218			1,583
Non-refundable deposits on sale		—			1,000
Liabilities related to assets held for sale		—			1,867
Other current liabilities		10,500			10,333
Total current liabilities		76,505			66,793
Debt, non-current		194,874			169,151
Operating lease liability, non-current		22,324			24,255
Deferred tax liability		29,875			27,082
Other liabilities		1,125			—
Total non-current liabilities		248,198			220,488
TOTAL LIABILITIES		324,703			287,281
Members' equity		157,578			197,267
Non-controlling interests		616			7,003
TOTAL MEMBERS’ EQUITY		158,194			204,270
TOTAL LIABILITIES AND MEMBERS' EQUITY	$	482,897		$	491,551

US GAAP FINANCIAL HIGHLIGHTS (UNAUDITED)

US GAAP Statements of Operations
US$ (thousands)	Q3'22				Q3'21				YTD'22				YTD'21
Retail revenue, net	$	48,314			$	30,795			$	136,426			$	85,038
Wholesale revenue, net		12,810				17,077				42,342				42,634
Other revenue, net		295				280				881				3,090
Total revenues, net		61,419				48,152				179,649				130,762
Cost of goods sold, retail		(26,097	)			(16,279	)			(70,331	)			(43,412	)
Cost of goods sold, wholesale		(14,096	)			(8,069	)			(27,968	)			(19,049	)
Total cost of goods sold		(40,193	)			(24,348	)			(98,299	)			(62,461	)
Gross profit		21,226				23,804				81,350				68,301
OPERATING EXPENSES
General and administrative		9,727				8,465				27,036				23,067
Compensation expense		15,271				10,699				42,045				32,236
Equity-based compensation expense		3,156				4,168				8,970				17,191
Marketing		735				583				2,396				992
Impairments, net		506				2,339				2,973				3,157
Loss on notes receivable		7,219				—				7,219				1,726
Write down (recovery) of assets held-for-sale		—				—				874				(8,616	)
Legal settlements (recoveries)		—				—				(335	)			322
Depreciation and amortization		1,047				4,044				6,019				9,670
Total operating expenses		37,661				30,298				97,197				79,745
Net operating loss		(16,435	)			(6,494	)			(15,847	)			(11,444	)
Income (loss) from investments, net		17				489				154				(777	)
Interest income from loans receivable		474				1,067				1,256				4,125
Interest expense		(5,688	)			(3,620	)			(15,989	)			(14,072	)
Other income, net		4,743				80				5,019				7,825
Total other loss		(454	)			(1,984	)			(9,560	)			(2,899	)
Loss before income taxes		(16,889	)			(8,478	)			(25,407	)			(14,343	)
Income tax expense		(8,109	)			(5,579	)			(24,105	)			(11,661	)
Net loss		(24,998	)			(14,057	)			(49,512	)			(26,004	)
Less: net loss attributable to non-controlling interests		(2,784	)			(1,761	)			(4,675	)			(3,347	)
Net loss attributable to Acreage Holdings, Inc.	$	(22,214	)		$	(12,296	)		$	(44,837	)		$	(22,657	)
Net loss per share attributable to Acreage Holdings, Inc. - basic and diluted:	$	(0.20	)		$	(0.12	)		$	(0.41	)		$	(0.22	)
Weighted average shares outstanding - basic and diluted		111,200				106,332				108,795				104,524

*NON-GAAP MEASURES, RECONCILIATION AND DISCUSSION (UNAUDITED)

This release includes Adjusted EBITDA, which is a non-GAAP performance measure that we use to supplement our results presented in accordance with U.S. GAAP. The Company uses Adjusted EBITDA to evaluate its actual operating performance and for planning and forecasting future periods. The Company believes that the adjusted results presented provide relevant and useful information for investors because they clarify the Company’s actual operating performance, make it easier to compare our results with those of other companies and allow investors to review performance in the same way as our management. Since these measures are not calculated in accordance with U.S. GAAP, they should not be considered in isolation of, or as a substitute for, net loss or our other reported results of operations as reported under U.S. GAAP as indicators of our performance, and they may not be comparable to similarly named measures from other companies.

The Company defines Adjusted EBITDA as net income before interest, income taxes and, depreciation and amortization and excluding the following: (i) income from investments, net (the majority of the Company's investment income relates to remeasurement to net asset value of previously-held interests in connection with our roll-up of affiliates, and the Company expects income from investments to be a non-recurring item as its legacy investment holdings diminish), (ii) equity-based compensation expense, (iii) non-cash impairment losses, (iv) transaction costs, (v) non-cash inventory adjustments and (v) other non-recurring expenses (other expenses and income not expected to recur).

Reconciliation of GAAP to Non-GAAP Measures
US$ (thousands, except per share amounts)	Q3'22				Q3'21				YTD'22				YTD'21
Net loss (GAAP)	$	(24,998	)		$	(14,057	)		$	(49,512	)		$	(26,004	)
Income tax expense		8,109				5,579				24,105				11,661
Interest expense (income), net		5,214				2,553				14,733				9,947
Depreciation and amortization		2,583				4,590				9,930				11,384
EBITDA (non-GAAP)*	$	(9,092	)		$	(1,335	)		$	(744	)		$	6,988
Adjusting items:
Loss (income) from investments, net		(17	)			(489	)			(154	)			777
Impairments, net		506				—				2,596				818
Non-cash inventory adjustments		6,286				—				6,286				—
Loss on extraordinary events		—				2,339				376				2,339
Loss on notes receivable		7,219				—				7,219				1,726
Write down (recovery) of assets held-for-sale		—				—				874				(8,616	)
Equity-based compensation expense		3,156				4,168				8,970				17,191
Legal settlements, net		—				—				(335	)			322
Gain on business divestiture		(3,200	)			(109	)			(3,496	)			(11,791	)
Other non-recurring expenses		3,989				1,924				6,267				6,425
Adjusted EBITDA (non-GAAP)*	$	8,847			$	6,498			$	27,859			$	16,179

FAQ

What were Acreage Holdings' Q3 2022 financial results?

Acreage Holdings reported $61.4 million in revenue, a 28% increase year-over-year, with an Adjusted EBITDA of $8.8 million.

How did gross margins change for Acreage in Q3 2022?

Gross margin decreased to 35% in Q3 2022 from 49% in Q3 2021 due to competitive pressures and inflation.

What strategic moves did Acreage make following Q3 2022?

Acreage entered a strategic arrangement with Canopy Growth for a full acquisition, aiming to strengthen its market position.

What is Acreage Holdings' cash position as of Q3 2022?

As of September 30, 2022, Acreage Holdings had $26.6 million in cash and cash equivalents.